Patent directory · USPTO A61K / A61P
Patents matching “Precision BioSciences, Inc.”
42 pharma patents match "Precision BioSciences, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 42 pharmaceutical patents matching "Precision BioSciences, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12410418
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
granted -
US 12351839
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
granted -
US 12006522
Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene
granted -
US 11993793
Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene
granted -
US 11866747
Engineered meganucleases that target human mitochondrial genomes
granted -
US 11851680
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted -
US 11786554
Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region gene
granted -
US 11788077
Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
granted -
US 11753630
Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene
granted -
US 11680254
Engineered meganucleases specific for recognition sequences in the PCSK9 gene
granted -
US 11453861
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted -
US 11384335
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted -
US 11286291
Co-stimulatory domains for use in genetically-modified cells
granted -
US 11278632
Engineered nucleases useful for treatment of hemophilia A
granted -
US 11274285
Engineered meganucleases specific for recognition sequences in the Hepatitis B virus genome
granted -
US 11266693
Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
granted -
US 11268065
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 11186822
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted -
US 11142750
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
granted -
US 11053484
Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene
granted -
US 11008548
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted -
US 10851358
Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome
granted -
US 10800833
Co-stimulatory domains for use in genetically-modified cells
granted -
US 10799535
Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
granted